Conversely, FADS2 overexpression attenuated M5‐induced inflammation, suggesting that FADS2 might mitigate the severity of psoriasis by modulating inflammatory responses in keratinocytes through NF‐κB signaling pathways, limiting excessive cytokine production and immune cell infiltration. This evidence concerns the gene FADS2 and psoriasis.